Aprea Therapeutics
- Pharmaceutical Preparations
- Doylestown, Pennsylvania
Compensation history
Top executives at Aprea Therapeutics received an average of $1M per person in annual compensation from 2018 to 2023.
Average pay of disclosed executives at Aprea Therapeutics
By year
Executives
We found six executives who work or worked at Aprea Therapeutics.
Oren Gilad
Aprea Therapeutics
Chief Executive Officer
John Hamill
Aprea Therapeutics
Chief Financial Officer
Scott Coiante
Aprea Therapeutics
Chief Financial Officer
Gregory Korbel
Aprea Therapeutics
Chief Operating Officer
Christian Schade
Aprea Therapeutics
Chief Executive Officer
Eyal Attar
Aprea Therapeutics
Chief Medical Officer
News
Aprea Therapeutics CFO John Hamill's 2023 pay jumps 62% to $908K
April 25, 2024
Aprea Therapeutics CEO Christian Schade's 2022 pay falls 58% to $1.4M
July 11, 2023
Aprea Therapeutics CEO Christian Schade's 2021 pay slips 17% to $3.2M
June 10, 2022
Aprea Therapeutics CEO Christian Schade's 2020 pay rises 6% to $3.9M
April 28, 2021
Aprea Therapeutics CEO Christian Schade's 2019 pay jumps 520% to $3.7M
April 29, 2020
About Aprea Therapeutics
- Industry classifications
- DivisionManufacturing
- Major groupChemicals And Allied Products
- Industry groupDrugs
- IndustryPharmaceutical Preparations
- Address3805 Old Easton Road, Doylestown, Pennsylvania 18902
- Phone617-463-9385
- Fiscal year endDecember 31
Source: SEC filings on April 25, 2024, July 11, 2023, April 28, 2021, and April 29, 2020.